ExpressPoints
Staying on TRK: Addressing Clinical Challenges and Improving Outcomes in NTRK Fusion–Positive Cancers

Clinical Care Options (CCO) commentary: Joel Neal, MD, discusses management of non-small-cell lung cancer (NSCLC) with uncommon EGFR mutations

Joel W. Neal, MD, PhD Released: May 20, 2022

Interactive expert-led video on targeted therapies for glioblastoma, from Clinical Care Options (CCO)

Andrew B. Lassman, MD
Program Director Timothy Cloughesy, MD Rimas V. Lukas, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: May 19, 2022 Expired: May 18, 2023

On-demand webcast on biomarker-driven care for patients with NSCLC, from Clinical Care Options (CCO)

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: May 12, 2022 Expired: May 11, 2023

Downloadable slides for oncologists, pharmacists, and nurses: Immunotherapy and chemotherapy for extensive-stage SCLC from Clinical Care Options (CCO)